Clinical Trials Browser

OTHER × Lymphoma, T-Cell, Peripheral × Injections × Clear all

NCT05006664 2021-09-01

Brentuximab Vedotin in Combination With CHEP in Patient With PTCL

Phase 2 Unknown

Lymphoma, T-Cell, Peripheral